Cargando…
Patient Centric Pharmaceutical Drug Product Design—The Impact on Medication Adherence
Medication adherence is a growing concern for public health and poor adherence to therapy has been associated with poor health outcomes and higher costs for patients. Interventions for improving adherence need to consider the characteristics of the individual therapeutic regimens according to the ne...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7023035/ https://www.ncbi.nlm.nih.gov/pubmed/31947888 http://dx.doi.org/10.3390/pharmaceutics12010044 |
_version_ | 1783498155712577536 |
---|---|
author | Menditto, Enrica Orlando, Valentina De Rosa, Giuseppe Minghetti, Paola Musazzi, Umberto Maria Cahir, Caitriona Kurczewska-Michalak, Marta Kardas, Przemysław Costa, Elísio Sousa Lobo, José Manuel Almeida, Isabel F |
author_facet | Menditto, Enrica Orlando, Valentina De Rosa, Giuseppe Minghetti, Paola Musazzi, Umberto Maria Cahir, Caitriona Kurczewska-Michalak, Marta Kardas, Przemysław Costa, Elísio Sousa Lobo, José Manuel Almeida, Isabel F |
author_sort | Menditto, Enrica |
collection | PubMed |
description | Medication adherence is a growing concern for public health and poor adherence to therapy has been associated with poor health outcomes and higher costs for patients. Interventions for improving adherence need to consider the characteristics of the individual therapeutic regimens according to the needs of the patients. In particular, geriatric and paediatric populations as well as dermatological patients have special needs/preferences that should be considered when designing drug products. Patient Centric Drug Product Pharmaceutical Design (PCDPD) offers the opportunity to meet the needs and preferences of patients. Packaging, orodispersible formulations, fixed dose combinations products, multiparticulate formulations, topical formulations and 3D printing are of particular relevance in a PCDPD process. These will be addressed in this review as well as their impact on medication adherence. |
format | Online Article Text |
id | pubmed-7023035 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-70230352020-03-12 Patient Centric Pharmaceutical Drug Product Design—The Impact on Medication Adherence Menditto, Enrica Orlando, Valentina De Rosa, Giuseppe Minghetti, Paola Musazzi, Umberto Maria Cahir, Caitriona Kurczewska-Michalak, Marta Kardas, Przemysław Costa, Elísio Sousa Lobo, José Manuel Almeida, Isabel F Pharmaceutics Review Medication adherence is a growing concern for public health and poor adherence to therapy has been associated with poor health outcomes and higher costs for patients. Interventions for improving adherence need to consider the characteristics of the individual therapeutic regimens according to the needs of the patients. In particular, geriatric and paediatric populations as well as dermatological patients have special needs/preferences that should be considered when designing drug products. Patient Centric Drug Product Pharmaceutical Design (PCDPD) offers the opportunity to meet the needs and preferences of patients. Packaging, orodispersible formulations, fixed dose combinations products, multiparticulate formulations, topical formulations and 3D printing are of particular relevance in a PCDPD process. These will be addressed in this review as well as their impact on medication adherence. MDPI 2020-01-03 /pmc/articles/PMC7023035/ /pubmed/31947888 http://dx.doi.org/10.3390/pharmaceutics12010044 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Menditto, Enrica Orlando, Valentina De Rosa, Giuseppe Minghetti, Paola Musazzi, Umberto Maria Cahir, Caitriona Kurczewska-Michalak, Marta Kardas, Przemysław Costa, Elísio Sousa Lobo, José Manuel Almeida, Isabel F Patient Centric Pharmaceutical Drug Product Design—The Impact on Medication Adherence |
title | Patient Centric Pharmaceutical Drug Product Design—The Impact on Medication Adherence |
title_full | Patient Centric Pharmaceutical Drug Product Design—The Impact on Medication Adherence |
title_fullStr | Patient Centric Pharmaceutical Drug Product Design—The Impact on Medication Adherence |
title_full_unstemmed | Patient Centric Pharmaceutical Drug Product Design—The Impact on Medication Adherence |
title_short | Patient Centric Pharmaceutical Drug Product Design—The Impact on Medication Adherence |
title_sort | patient centric pharmaceutical drug product design—the impact on medication adherence |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7023035/ https://www.ncbi.nlm.nih.gov/pubmed/31947888 http://dx.doi.org/10.3390/pharmaceutics12010044 |
work_keys_str_mv | AT mendittoenrica patientcentricpharmaceuticaldrugproductdesigntheimpactonmedicationadherence AT orlandovalentina patientcentricpharmaceuticaldrugproductdesigntheimpactonmedicationadherence AT derosagiuseppe patientcentricpharmaceuticaldrugproductdesigntheimpactonmedicationadherence AT minghettipaola patientcentricpharmaceuticaldrugproductdesigntheimpactonmedicationadherence AT musazziumbertomaria patientcentricpharmaceuticaldrugproductdesigntheimpactonmedicationadherence AT cahircaitriona patientcentricpharmaceuticaldrugproductdesigntheimpactonmedicationadherence AT kurczewskamichalakmarta patientcentricpharmaceuticaldrugproductdesigntheimpactonmedicationadherence AT kardasprzemysław patientcentricpharmaceuticaldrugproductdesigntheimpactonmedicationadherence AT costaelisio patientcentricpharmaceuticaldrugproductdesigntheimpactonmedicationadherence AT sousalobojosemanuel patientcentricpharmaceuticaldrugproductdesigntheimpactonmedicationadherence AT almeidaisabelf patientcentricpharmaceuticaldrugproductdesigntheimpactonmedicationadherence |